N2Growth Blog

JANUARY 10, 2024

The Importance of Executive Search and Leadership Development to the Growth of the Life Sciences Industry Ensuring that organizations have access to top talent for key leadership positions and that talent is sufficiently supported and developed is critical to the growth of the life sciences industry.

Biotech 97

Biotech Leadership Recruiting Artificial Inteligence 97

TechCrunch

FEBRUARY 11, 2021

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. ” Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies. ’,” said Solomon.

Artificial Inteligence 305

Artificial Inteligence Machine Learning Biotech Chemicals 305

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. The company plans to use the tech to develop gene therapies for monogenic liver diseases and cell therapies for autoimmune diseases.

Biotech 96

Biotech Artificial Intelligence Artificial Inteligence Hotels 96

Crunchbase News

SEPTEMBER 6, 2024

Safe Superintelligence , $1B, artificial intelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital. Arsenal Biosciences , $325M, biotech: The big biotech raise of the week went to South San Francisco-based Arsenal Biosciences.

Biotech 114

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 114

Crunchbase News

MARCH 8, 2024

However, this week it was clearly biotech leading the way, with three startups from the sector nabbing spots in the top five. Alumis , $259M, biotech: This week saw the biggest biotech raise of the year thus far. The startup is developing oral therapies for patients with immune-mediated diseases.

Biotech 85

Biotech Pharmaceuticals Systems Review Artificial Intelligence 85

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. PayPal co-founder Peter Thiel invested in Unity Biotechnology , which is developing drugs to treat diseases that accompany aging. And Ethereum founder Vitalik Buterin invested $2.4

Research 261

Research Biotech Nonprofit Comparison 261

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. “Next year, we anticipate having our first drug candidate enter the late preclinical phase of development and regulatory work for an IND (investigational new drug) filing with the FDA, and starting the clinical trials in 2023.”

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Crunchbase News

SEPTEMBER 13, 2024

Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.

Biotech 73

Biotech Artificial Inteligence Artificial Intelligence Healthcare 73

Crunchbase News

OCTOBER 1, 2024

However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Safe Superintelligence , $1B, artificial intelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital.

Biotech 98

Biotech Artificial Intelligence Artificial Inteligence Travel 98

Crunchbase News

JUNE 7, 2024

Department of Energy ’s Milestone-Based Fusion Development Program. Pika , $80M, artificial intelligence: It never takes us long to get to an AI startup on this list. tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. No lead investor was announced.

Energy 107

Energy Biotech 3D Artificial Intelligence 107

TechCrunch

MAY 20, 2022

With cloud-based servers and sophisticated, yet inexpensive, sensors both on the body and off, patients can be monitored at home more effectively than in a hospital, especially when the sensor data is analyzed with artificial intelligence (AI) and machine-learning technology. Opportunities for digital biomarkers.

Artificial Inteligence 231

Artificial Inteligence Artificial Intelligence Healthcare Technical Review 231

Crunchbase News

JUNE 4, 2024

xAI , $6B, artificial intelligence: Elon Musk ’s generative AI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI. CoreWeave , $1.1B, artificial intelligence: Another big AI-related funding round.

Artificial Inteligence 104

Artificial Inteligence Biotech Artificial Intelligence Generative AI 104

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificial intelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.

Lambda 94

Lambda Biotech Artificial Intelligence Artificial Inteligence 94

Crunchbase News

APRIL 26, 2024

This week’s theme was definitely AI, as many of the largest rounds went to startups using AI in coding or biotech. Xaira Therapeutics , $1B, biotech: The biggest round this week was really big. Augment , $227M, artificial intelligence: AI coding startups made a big splash this week. billion in March 2023.

Biotech 96

Biotech Artificial Intelligence Artificial Inteligence Healthcare 96

Crunchbase News

JULY 10, 2024

North American startup funding perked up in the second quarter, bolstered by early-stage investment around artificial intelligence. Artificial intelligence remains the runaway favorite investment theme, as AI-focused startups pulled in $16.8 Overall, investors put $45.3 and Canadian startups in the second quarter of 2024.

Biotech 124

Biotech Artificial Intelligence Artificial Inteligence Report 124

Crunchbase News

JUNE 14, 2024

AI, biotech, space tech and cybersecurity also saw good-sized raises. AlphaSense , $650M, artificial intelligence: AI-driven market intelligence platform AlphaSense raised $650 million in funding co-led by Viking Global Investors and BDT & MSD Partners at a $4 billion valuation — a 75% increase from just nine months ago.

Biotech 104

Biotech Technical Review Artificial Intelligence Artificial Inteligence 104

Crunchbase News

AUGUST 9, 2024

Aside from that, the week saw some big rounds from cybersecurity, travel and of course, biotech. The company will use some of the new proceeds for the development of Arsenal-1 — a more than 5 million-square-foot production space designed to produce tens of thousands of autonomous military systems annually.

Biotech 91

Biotech Artificial Inteligence Industry Artificial Intelligence 91

CIO

APRIL 17, 2024

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. Helping software developers write and test code Similarly in tech, companies are currently open about some of their use cases, but protective of others.

Software Review 194

Software Review Enterprise Generative AI Artificial Inteligence 194

Crunchbase News

MARCH 1, 2024

The quintet that did raise big were from three of the usual sectors — biotech, energy and AI — however one was from a sector we don’t normally see — a vertical farming agtech startup. Fervo Energy, a geothermal developer, locked up a big $244 million round led by shale oil and gas firm Devon Energy Corp.

Energy 95

Energy Biotech Artificial Intelligence Artificial Inteligence 95

Crunchbase News

AUGUST 16, 2024

Halda Therapeutics , $126M, biotech: The big biotech round of the week came from New Haven, Connecticut-based Halda Therapeutics, a biotech startup developing therapies for prostate cancer and breast cancer, which raised a $126 million Series B extension from investors including Deep Track Capital and RA Capital Management.

Biotech 102

Biotech Artificial Intelligence Artificial Inteligence Healthcare 102

Crunchbase News

DECEMBER 9, 2024

Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. Top biotech performers Biotech companies that debuted on public markets this year also saw plenty of ups and downs.

Biotech 93

Biotech Film Performance Marketing 93

Crunchbase News

OCTOBER 4, 2024

OpenAI , $6.6B, artificial intelligence: OpenAI announced its long-awaited raise of $6.6 Poolside , $500M, artificial intelligence: Most weeks a half-billion-dollar round would top this list — but this isn’t most weeks. The startup builds artificial intelligence software for programmers.

Biotech 83

Biotech Artificial Intelligence Artificial Inteligence Energy 83

Crunchbase News

OCTOBER 4, 2024

The past quarter was a quirky one for North America startup funding, with a slowdown in some pockets counterbalanced by continued high enthusiasm around artificial intelligence, Crunchbase data shows. While the IPO market wasn’t especially active, we did see a handful of public offerings, predominantly in the biotech sector.

Biotech 110

Biotech Technical Review Artificial Intelligence Artificial Inteligence 110

Crunchbase News

MAY 24, 2024

Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. Scale AI , $1B, artificial intelligence: This week was like many — one topped with a big AI round. The startup will use the new cash to grow its user base and add developer tools.

Artificial Inteligence 94

Artificial Inteligence Biotech Artificial Intelligence Healthcare 94

Crunchbase News

NOVEMBER 1, 2024

OpenAI , $6.6B, artificial intelligence: OpenAI announced its long-awaited raise of $6.6 tied) Poolside , $500M, artificial intelligence: Poolside closed a $500 million Series B led by Bain Capital Ventures. The startup builds artificial intelligence software for programmers. billion, per Crunchbase.

Biotech 94

Biotech Energy Artificial Intelligence Artificial Inteligence 94

TechCrunch

APRIL 19, 2022

The three met while working together at Leap Motion, the now-defunct startup developing motion sensors for desktops and augmented reality headsets. But [I] had a pharmaceutical industry background and it soon became apparent that there had been no investment in machine learning as a technology for pharma development,” Fisher said.

Development 170

Development Artificial Inteligence Pharmaceuticals Machine Learning 170

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 106

Biotech Generative AI Artificial Intelligence Artificial Inteligence 106

Crunchbase News

MAY 2, 2024

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets. Let’s take a look.

Biotech 113

Biotech Blockchain Generative AI Energy 113

Crunchbase News

JULY 19, 2024

Eight startups raised $100 million or more this week as a biotech and financial services company led the way. The startup is focused on developing therapeutics for the treatment of cardiovascular diseases. Scorpion Therapeutics , $150M, biotech: Yet another big biotech round. Notice anything missing?

Pharmaceuticals 96

Pharmaceuticals Biotech Artificial Inteligence Automotive 96

TechCrunch

DECEMBER 28, 2021

Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Outset-backed Zenno Astronautics, for example, is developing a fuel-free satellite propulsion system that uses magnets powered by solar panels.

Technical Review 236

Technical Review Blockchain Biotech Software Review 236

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Earlier in March, shares of Astera Labs — a developer of data center connectivity technology with use cases in generative AI — soared after its initial public offering on the Nasdaq.

Biotech 106

Biotech Artificial Intelligence Artificial Inteligence Energy 106

Crunchbase News

JULY 26, 2024

All 10 rounds hit $100 million or more, this time with space tech and biotech leading the way. The San Francisco-based startup develops small broadband communications satellites for telecoms, and plans to have more than 100 of its first-generation satellites operating in orbit by 2030. Check out last week’s biggest funding rounds here.

Biotech 107

Biotech Artificial Intelligence Artificial Inteligence Report 107

Crunchbase News

JULY 12, 2024

After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. based companies? Check out The Crunchbase Megadeals Board.

Biotech 89

Biotech Artificial Intelligence Artificial Inteligence Healthcare 89

Crunchbase News

AUGUST 2, 2024

Outpace Bio , $144M, biotech: The big biotech raise of the week came from Outpace Bio. The biotech uses AI-powered protein design to program immune cells battling tumors. The company also uses artificial intelligence to help members get care faster. It is the company’s first disclosed round, per Crunchbase.

Biotech 95

Biotech Artificial Inteligence Artificial Intelligence Insurance 95

TechCrunch

APRIL 6, 2022

6 questions investors should ask when evaluating psychedelic biotech companies. With plans to raise a $25 million fund and more than $15 million already invested, PsyMed Ventures focuses on early-stage startups developing psychedelic therapeutics. 6 questions investors should ask when evaluating psychedelic biotech companies.

Marketing 235

Marketing Biotech Retail 3D 235

TechCrunch

OCTOBER 20, 2021

Healx is one of a host of startups invested in using AI for drug development and identification. AI-based drug development is becoming a bigger piece of the AI landscape. Funding for AI-based drug development skyrocketed to $13.5 Healx’s approach happens to be artificial intelligence. .

Artificial Inteligence 243

Artificial Inteligence Study Artificial Intelligence Pharmaceuticals 243

Crunchbase News

SEPTEMBER 27, 2024

With all the venture funding in biotech , it is no surprise that one of the largest deals was Merck ’s acquisition of New York-based eye disease therapy company Eyebiotech. For those acquirers, sectors have included cloud management, AI tooling, security and asset management and content development platforms.

Trends 126

Trends Biotech Real Estate Artificial Intelligence 126